Efficacy of preoperative tranexamic acid administration for intraoperative blood loss reduction in high-risk cesarean delivery: A randomized controlled trial
Article Sidebar
Main Article Content
Abstract
Objective: To evaluate the efficacy of preoperative tranexamic acid (TXA) in reducing intraoperative blood loss in high-risk cesarean deliveries.
Materials and Methods: A randomized controlled trial was conducted with 50 pregnant women with gestational age over 34 weeks and a high risk of postpartum hemorrhage (PPH) (e.g., previous cesarean delivery, fetal macrosomia, and placenta previa) who underwent cesarean delivery using spinal anesthesia. The intervention group received one gram of TXA intravenously before skin incision, and 0.9% sodium chloride solution (NSS) was used in the placebo group. The primary outcome was the measurement of intraoperative blood loss.
Results: The TXA group showed significantly lower intraoperative blood loss when compared to the placebo group (495.8 ± 294.6 ml vs. 925.6 ± 448.9 ml, mean difference: -429.8 ml, 95% CI: -645.8 to -213.9, p < 0.001). The incidence of blood loss >1,000 ml was also significantly lower in the TXA group (8% vs. 36%, relative risk = 0.22, 95% CI: 0.05 to 0.92, p = 0.039), and fewer significantly decreased hemoglobin levels were observed in the TXA group in comparison with the placebo group (1.1 ± 7.0 g/dL vs. 6.9 ± 9.6 g/dL, mean difference: -5.7 g/dL, 95% CI: -10.5 to -0.9, p = 0.02). Additionally, the placebo group required more additional uterotonic drugs (8% vs. 28%, p = 0.06). No serious adverse effects were observed in this study.
Conclusion: TXA effectively reduced intraoperative blood loss in women at high risk of PPH who underwent cesarean deliveries.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Jauniaux E, Berghella V. The modern caesarean section. 1st ed. Oxford: Oxford University, 2016: 49–68.
Say L, Chou D, Gemmill A, Tunçalp Ö, Moller A-B, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323-e33.
Hawkins JL, Chang J, Palmer SK, Gibbs CP, Callaghan WM. Anesthesia-Related Maternal Mortality in the United States: 1979–2002. Obstet Gynecol. 2011;117(1):69-74.
Practice Bulletin No. 183: Postpartum Hemorrhage. Obstet Gynecol. 2017;130(4):e168-e86.
Cunningham FG, Leveno KJ, Dashe JS, Hoffman BL, Spong CY, Casey BM. Williams Obstetrics. 26th ed. Chicago: McGraw-Hill, 2022: 731-45.
Hofer S, Blaha J, Collins PW, Ducloy-Bouthors A-S, Guasch E, Labate F, et al. Haemostatic support in postpartum haemorrhage: A review of the literature and expert opinion. Eur J Anaesthesiol. 2023;40(1):29-38.
Bolton TJ, Randall K, Yentis SM. Effect of the Confidential Enquiries into Maternal Deaths on the use of Syntocinon® at Caesarean section in the UK. Anaesthesia. 2003;58(3):277-9.
Chornenki NLJ, Um KJ, Mendoza PA, Samienezhad A, Swarup V, Chai-Adisaksopha C, et al. Risk of venous and arterial thrombosis in non-surgical patients receiving systemic tranexamic acid: A systematic review and meta-analysis. Thromb Res. 2019;179:81-6.
Drugs.com. Tranexamic acid Pregnancy and Breastfeeding Warnings [Internet]. 2023 [cited 2023 Apr 12]. Available from: Tranexamic acid Use During Pregnancy | Drugs.com
Al-dardery NM, Abdelwahab OA, Abouzid M, Albakri K, Elkhadragy A, Katamesh BE, et al. Efficacy and safety of tranexamic acid in prevention of postpartum hemorrhage: a systematic review and meta-analysis of 18,649 patients. BMC Pregnancy Childbirth. 2023;23(1):817.
Eyeberu A, Getachew T, Amare G, Yadeta E, Lemi M, Bekele H, et al. Use of tranexamic acid in decreasing blood loss during and after delivery among women in Africa: a systematic review and meta-analysis. Arch Gynecol Obstet. 2023;308(3):709-25.
Maged AM, Helal OM, Elsherbini MM, Eid MM, Elkomy RO, Dahab S, et al. A randomized placebo-controlled trial of preoperative tranexamic acid among women undergoing elective cesarean delivery. Int J Gynecol Obstet. 2015;131(3):265-8.
Mavrides E, Allard S, Chandraharan E, Collins P, Green L, Hunt BJ, et al. Prevention and Management of Postpartum Haemorrhage: Green-top Guideline No. 52. BJOG. 2016;124(5):e106-e49.
Knight M, Callaghan WM, Berg C, Alexander S, Bouvier-Colle M-H, Ford JB, et al. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth. 2009;9(1):55.
Kramer MS, Berg C, Abenhaim H, Dahhou M, Rouleau J, Mehrabadi A, et al. Incidence, risk factors, and temporal trends in severe postpartum hemorrhage. Am J Obstet Gynecol. 2013;209(5):449.e1-.e7.
Kramer MS, Dahhou M, Vallerand D, Liston R, Joseph KS. Risk Factors for Postpartum Hemorrhage: Can We Explain the Recent Temporal Increase? J Obstet Gynaecol Can. 2011;33(8):810-9.
Lutomski J, Byrne B, Devane D, Greene R. Increasing trends in atonic postpartum haemorrhage in Ireland: an 11-year population-based cohort study. BJOG. 2012;119(3):306-14.
Nyfløt LT, Sandven I, Stray-Pedersen B, Pettersen S, Al-Zirqi I, Rosenberg M, et al. Risk factors for severe postpartum hemorrhage: a case-control study. BMC Pregnancy Childbirth. 2017;17(1):17.
Qayum K, Kar I, Sofi J, Panneerselvam H. Single- Versus Double-Layer Uterine Closure After Cesarean Section Delivery: A Systematic Review and Meta-Analysis. Cureus. 2021;13(9):e18405.
Quantitative Blood Loss in Obstetric Hemorrhage: ACOG COMMITTEE OPINION SUMMARY, Number 794. Obstet Gynecol. 2019;134(6):1368-9.
Gari A, Hussein K, Daghestani M, Aljuhani S, Bukhari M, Alqahtani A, et al. Estimating blood loss during cesarean delivery: A comparison of methods. J Taibah Univ Med Sci. 2022;17(5):732-6.
Gerdessen L, Meybohm P, Choorapoikayil S, Herrmann E, Taeuber I, Neef V, et al. Comparison of common perioperative blood loss estimation techniques: a systematic review and meta-analysis. J Clin Monit Comput. 2021;35(2):245-58.
Shalaby MA, Maged AM, Al-Asmar A, El Mahy M, Al-Mohamady M, Rund NMA. Safety and efficacy of preoperative tranexamic acid in reducing intraoperative and postoperative blood loss in high-risk women undergoing cesarean delivery: a randomized controlled trial. BMC Pregnancy Childbirth. 2022;22(1):201.
Abdel-Fatah AT, Ibrahim SA-S, Mohammed SAA, Hamed BM. Effectiveness of Tranexamic Acid in Preventing Postpartum Hemorrhage in Cesarean Delivery of High-Risk Pregnancy. Egypt J Hosp Med. 2022;86(1):238-41.
Bellos I, Pergialiotis V. Tranexamic acid for the prevention of postpartum hemorrhage in women undergoing cesarean delivery: an updated meta-analysis. Am J Obstet Gynecol. 2022;226(4):510-23.e22.
Sucharit C. Efficacy of tranexamic acid for reducing blood loss after caesarean section on women with previous caesarean sections: A randomized controlled trial. J Med Health Sci. 2022;29(3):69-80.
Oseni RO, Zakari M, Adamou N, Umar UA. Effectiveness of preoperative tranexamic acid in reducing blood loss during caesarean section at Aminu Kano Teaching Hospital, Kano: a randomized controlled trial. Pan Afr Med J. 2021;39(1).
Ruka W. The Efficacy of Intravenous Tranexamic Acid (TXA) in Preventing Acute Postpartum Hemorrhage after Elective Cesarean Section; a Randomized Controlled Trial in Phra Nakhon Si Ayutthaya Hospital. JPMAT. 2021;11(3):628-40.